Compounding Dosage Drug Pricing 
Drug Patent Watch
DECEMBER 18, 2024
Each stage of drug development can potentially yield patentable inventions. From initial compound discovery to formulation improvements, every step offers opportunities for patent protection.” Balancing Profit and Public Health Pharmaceutical companies face increasing scrutiny over drug pricing and access.
Pharmacy Times
JUNE 23, 2025
This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
JULY 16, 2025
1 In response to this immense demand, coupled with high costs and accessibility issues, compounded alternatives have emerged as a seemingly pragmatic solution. However, these compounded GLP-1s are creating a significant, often underestimated, legal, reputational, and financial minefield for startups and the broader life sciences industry.
European Pharmaceutical Review
JUNE 24, 2022
The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. This obviously presents a huge magnitude of risk for drug developers,” he noted.
Drug Patent Watch
DECEMBER 19, 2024
Let’s explore the key components: Active Pharmaceutical Ingredients (APIs) Patents on APIs are the foundation of any drug patent portfolio. These protect the core molecule or compound that gives a drug its therapeutic effect. Q: What role does patent portfolio management play in drug pricing?
Expert insights. Personalized for you.
96 
Let's personalize your content